XML 18 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814
DIVESTITURES (Details) - USD ($)
$ in Millions
3 Months Ended
Jul. 10, 2014
Jul. 01, 2014
Sep. 30, 2014
Restylane, Perlane, Emeryel, Scilptra, and Dysport [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Divestiture proceeds $ 1,400    
Divestiture net gain     $ 324
Cost to sell for divestiture $ 43    
Metronidazole 1.3 Percent Vaginal Gel Antibiotic Development Product [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Divestiture proceeds   $ 10  
Divestiture net gain     $ (59)
Royalty receivable period   3 years